-
Google Bets on Health
Bloomberg | "The most you can lose is all your money," says Bill Maris, the founder of Google Ventures who is making big investments in the riskier, more highly regulated fields of health other Silicon Valley investors have avoided.
Feb 15, 2016
-
Legal Tussle Delays Launch of Huge Toxicity Database
Nature News | Toxicologists at Johns Hopkins have charted the health risks of nearly 10,000 chemicals to help predict the toxicity of untested substances.
Feb 11, 2016
-
10X Genomics Reveals Upgraded Platform with New Features for Single-Cell RNA Sequencing
Bio-IT World | 10X Genomics, whose GemCode platform allows for much better structural variant resolution and haplotype phasing during short-read sequencing experiments, has released a new system, Chromium, that builds on the efficiency of GemCode and can label RNA molecules from individual cells.
Feb 11, 2016
-
VeriStor Integrates SwiftStack Object Storage
Bio-IT World Brief | VeriStor is integrating SwiftStack’s object storage into its enterprise cloud services portfolio, the companies announced this week.
Feb 10, 2016
-
AbbVie Invests in Synthetic Microbes for Treatment of Intestinal Disorders
Bio-IT World | This morning, AbbVie announced a partnership with Synlogic of Cambridge, Mass., to target inflammatory bowel disease with a strain of genetically engineered microbes that can sense and respond to symptoms as they occur.
Feb 10, 2016
-
Fidelity, Biogen, Sanofi Join $45M Bet on Alzheimer's and Parkinson's Startup
Forbes | The drug industry is pouring billions into R&D against Alzheimer's disease. Yet many people in the business will tell you not nearly enough is known about the underlying biology.
Feb 10, 2016
-
Sure Genomics Wants to Sell Private Genetic Profiles for $2500
The Verge | Sure Genomics, a startup based in Utah, launched a whole genome testing service today, but its plan to report a host of important health results is really testing the FDA.
Feb 9, 2016
-
The Search for Schizophrenia Genes
Slate | Larger and larger genetic studies are finding smaller and smaller effect sizes. What does this mean for drug development, clinical practice, and our view of mental illness?
Feb 8, 2016
-
New Type of CRISPR Screen Probes the Regulatory Genome
Bio-IT World | Scientists at MIT and Brigham and Women's Hospital have invented a "multiplexed editing regulatory assay" (MERA) to test large swathes of the genome in parallel for regulatory elements that can turn gene activity on and off over the course of a cell's development.
Feb 8, 2016
-
Debugging Science Experiments at Elemental Machines
Xconomy | A Cambridge startup is trying to remove extraneous variables from experiments with a "smart lab" that can better control for simple factors like temperature and humidity.
Feb 3, 2016
-
Mobile DNA Sequencing in the Ebola Epidemic
Bio-IT World | The results of a months-long effort to sequence virus samples in the middle of the largest Ebola outbreak in history, using the handheld MinION DNA sequencer and a miniature mobile lab, have been published in Nature.
Feb 3, 2016


